Skip to main content

GRI Bio, Inc.

GRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001824293

No open-market purchases or sales by GRI Bio, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q3 2026, worth $228.1K in total; no superinvestor holds it.

Key figures

Market capClose on Nov 20, 2026
$2.45M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +1 vs. previous quarter
12
13F valueReported value at the end of Q3 2026
$228.1K
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$12.0M
No comparable prior period
Free cash flow, FY2025
-$10.2M
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
66.5K
Shares sold short
Change
+395
+0.6% vs. previous
Days to cover
1.56
At average daily volume

Superinvestors holding GRI, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding GRI at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by GRI Bio, Inc. insiders from Form 4, newest first.

No open-market purchases or sales by GRI Bio, Inc. insiders are on file.

Top 10 13F holders, Q3 2026

See all 12 holders

The largest institutional positions in GRI Bio, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding GRI in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Jane Street Group, LLC30,721$59.3K0.00%+30,721New
HRT Financial LP26,402$50.0K0.00%−2,382−8.3%Reduced
Vanguard Capital Management LLC21,368$41.2K0.00%00.0%Unchanged
UBS Group AG19,029$36.7K0.00%+14,109+286.8%Added
Geode Capital Management, LLC10,045$19.4K0.00%−3,824−27.6%Reduced
Morgan Stanley8,737$16.9K0.00%00.0%Unchanged
Citigroup Inc1,645$3.17K0.00%+1,645New
Tower Research Capital LLC (TRC)731$1.41K0.00%−1,703−70.0%Reduced
BlackRock, Inc.7$140.00%00.0%Unchanged
Caitong International Asset Management Co., Ltd3$60.00%+1+50.0%Added

Holders of 5% or more of GRI

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of GRI Bio, Inc..

Largest holders of GRI from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Intracoastal Capital, LLC13G/A9.99%1.10M shares0.00 ppfrom 9.99%Apr 7, 20253 filingsFeb 13, 2026SEC
MJL Manager LLC13G7.30%159.4K sharesNewNov 12, 20261 filingNov 12, 2026SEC